Using continuous glucose monitors in healthy newborn babies
Part of Hormones & metabolism clinical trials.
This study checks whether a continuous glucose monitor can safely track blood sugar levels in newborns. It may help doctors better understand glucose patterns in babies at birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The baby’s mother is at least 18 years old
- The baby was born at the right size for their due date or was larger than expected
- The baby was born at least 38 weeks gestation
- The baby weighs at least 2.5 kilograms at birth
- A skin-thickness measurement on the upper butt area is at least 1 inch
- The baby does not have signs of poor growth in the womb
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a continuous glucose monitor (a small sensor placed on the skin) to track blood sugar levels in newborns whose mothers used insulin for gestational diabetes. The goal is to see if this monitoring helps prevent low blood sugar in babies.
This study checks how well continuous glucose monitors work in newborns. It aims to improve care for babies by making glucose monitoring easier and less invasive.
This study tests if using a continuous glucose monitor (CGM), a small device that tracks blood sugar, can help children and teens with obesity understand their body better and improve their health.
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study tests a continuous glucose monitor (CGM) in newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen around birth. The CGM tracks sugar levels to help doctors manage care better.
Hear when a new Neonatal Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.